Asia Pacific Glioma Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)

No. of Pages: 97    |    Report Code: BMIRE00029266    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Glioma Treatment Market

TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Glioma Treatment Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Government Funding for Glioma Treatment
4.1.2 Increase in Prevalence of High-Grade Glioma
4.2 Key Market Restraints
4.2.1 High Cost of Diagnosis
4.3 Key Market Opportunities
4.3.1 Advancements in Healthcare Sector in Emerging Economies
4.4 Future Trends
4.4.1 Surge in Drug Approvals for Glioma Treatment
4.5 Impact Analysis:
5. Glioma Treatment Market - Asia Pacific Market Analysis
5.1 Asia Pacific Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
6. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease
6.1 Overview
6.2 Asia Pacific Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
6.3 Astrocytoma
6.3.1 Overview
6.3.2 Astrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Oligoastrocytoma
6.4.1 Overview
6.4.2 Oligoastrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Oligodendroglioma
6.5.1 Overview
6.5.2 Oligodendroglioma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type
7.1 Overview
7.2 Asia Pacific Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Surgery
7.3.1 Overview
7.3.2 Surgery: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Chemotherapy
7.4.1 Overview
7.4.2 Chemotherapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Radiation Therapy
7.5.1 Overview
7.5.2 Radiation Therapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade
8.1 Overview
8.2 Asia Pacific Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
8.3 Low Grade
8.3.1 Overview
8.3.2 Low Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Grade I: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Grade II: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 High Grade
8.4.1 Overview
8.4.2 High Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Grade III: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.2 Grade IV: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Asia Pacific Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospital & Clinics
9.3.1 Overview
9.3.2 Hospital & Clinics: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Glioma Treatment Market - Country Analysis
10.1 Overview
10.1.1 Asia Pacific Glioma Treatment Market, by Country
10.1.1.1 China
10.1.1.1.1 China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 China: Asia Pacific Glioma Treatment Market, by Disease
10.1.1.1.3 China: Asia Pacific Glioma Treatment Market, by Treatment Type
10.1.1.1.4 China: Asia Pacific Glioma Treatment Market, by Grade
10.1.1.1.4.1 China: Asia Pacific Glioma Treatment Market, by Low Grade
10.1.1.1.4.2 China: Asia Pacific Glioma Treatment Market, by High Grade
10.1.1.1.5 China: Asia Pacific Glioma Treatment Market, by End User
10.1.1.2 Japan
10.1.1.2.1 Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Japan: Asia Pacific Glioma Treatment Market, by Disease
10.1.1.2.3 Japan: Asia Pacific Glioma Treatment Market, by Treatment Type
10.1.1.2.4 Japan: Asia Pacific Glioma Treatment Market, by Grade
10.1.1.2.4.1 Japan: Asia Pacific Glioma Treatment Market, by Low Grade
10.1.1.2.4.2 Japan: Asia Pacific Glioma Treatment Market, by High Grade
10.1.1.2.5 Japan: Asia Pacific Glioma Treatment Market, by End User
10.1.1.3 India
10.1.1.3.1 India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 India: Asia Pacific Glioma Treatment Market, by Disease
10.1.1.3.3 India: Asia Pacific Glioma Treatment Market, by Treatment Type
10.1.1.3.4 India: Asia Pacific Glioma Treatment Market, by Grade
10.1.1.3.4.1 India: Asia Pacific Glioma Treatment Market, by Low Grade
10.1.1.3.4.2 India: Asia Pacific Glioma Treatment Market, by High Grade
10.1.1.3.5 India: Asia Pacific Glioma Treatment Market, by End User
10.1.1.4 South Korea
10.1.1.4.1 South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.2 South Korea: Asia Pacific Glioma Treatment Market, by Disease
10.1.1.4.3 South Korea: Asia Pacific Glioma Treatment Market, by Treatment Type
10.1.1.4.4 South Korea: Asia Pacific Glioma Treatment Market, by Grade
10.1.1.4.4.1 South Korea: Asia Pacific Glioma Treatment Market, by Low Grade
10.1.1.4.4.2 South Korea: Asia Pacific Glioma Treatment Market, by High Grade
10.1.1.4.5 South Korea: Asia Pacific Glioma Treatment Market, by End User
10.1.1.5 Australia
10.1.1.5.1 Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.2 Australia: Asia Pacific Glioma Treatment Market, by Disease
10.1.1.5.3 Australia: Asia Pacific Glioma Treatment Market, by Treatment Type
10.1.1.5.4 Australia: Asia Pacific Glioma Treatment Market, by Grade
10.1.1.5.4.1 Australia: Asia Pacific Glioma Treatment Market, by Low Grade
10.1.1.5.4.2 Australia: Asia Pacific Glioma Treatment Market, by High Grade
10.1.1.5.5 Australia: Asia Pacific Glioma Treatment Market, by End User
10.1.1.6 Rest of Asia Pacific
10.1.1.6.1 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.2 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Disease
10.1.1.6.3 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Treatment Type
10.1.1.6.4 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Grade
10.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Low Grade
10.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by High Grade
10.1.1.6.5 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by End User
11. Asia Pacific Glioma Treatment Market Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 F. Hoffmann-La Roche Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck & Co Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sun Pharmaceutical Industries Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Amgen Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Pfizer Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Amneal Pharmaceuticals Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Biocon Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms


List of Tables
Table 1. Asia Pacific Glioma Treatment Market Segmentation
Table 2. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 3. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 4. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 5. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 6. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 7. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 8. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 9. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 10. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 11. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 12. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 13. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 15. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 16. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 17. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 18. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 19. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 20. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 21. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 22. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 23. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 24. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
Table 25. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 26. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 27. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 28. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 29. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 30. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 31. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 32. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 33. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 34. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 35. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 36. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 37. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 38. Organic Developments Done By Companies
Table 39. Inorganic Developments Done By Companies
Table 40. Glossary of Terms, Asia Pacific glioma treatment market

List of Figures
Figure 1. Asia Pacific Glioma Treatment Market Segmentation, By Country
Figure 2. Asia Pacific Glioma Treatment Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Asia Pacific Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 6. Astrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Oligoastrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Oligodendroglioma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 10. Surgery: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chemotherapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Radiation Therapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Asia Pacific Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
Figure 15. Low Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Grade I: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Grade II: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. High Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Grade III: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Grade IV: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Asia Pacific Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 22. Hospital & Clinics: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ambulatory Surgical Centers: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 25. Asia Pacific Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 26. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Asia Pacific Glioma Treatment Market

1. Amgen Inc 
2. Amneal Pharmaceuticals Inc
3. Biocon Ltd
4. F. Hoffmann-La Roche Ltd
5. Merck & Co Inc
6. Pfizer Inc
7. Sun Pharmaceutical Industries Ltd
8. Teva Pharmaceutical Industries Ltd